Paolo Tombesi

Chief Financial Officer, INSMED Inc.

Companies

Turning Point Therapeutics, Inc.Chief financial officer Jul 27, 2021 to Aug 17, 2022¹
Epizyme, Inc.Chief financial officer Aug 21, 2019 to Feb 5, 2021²
INSMED IncChief financial officer Jun 5, 2017 to Jan 7, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Turning Point Therapeutics, Inc.0 shares⁴Aug 17, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 17, 2022Returned to company 29,778 shares at $76.00 of Turning Point Therapeutics, Inc.⁴
Jul 27, 2022Sold 1,183 shares at $74.94 of Turning Point Therapeutics, Inc.⁵
Feb 9, 2022Granted 16,283 shares of Turning Point Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTurning Point Therapeutics, Inc., Chief financial officer
2
SEC EDGAREpizyme, Inc., Chief financial officer
3
SEC EDGARINSMED Inc, Chief financial officer
4
SEC EDGARTurning Point Therapeutics, Inc. shares after the filing of Aug 17, 2022
5
SEC EDGARForm 4 filed Jul 29, 2022
6
SEC EDGARForm 4 filed Feb 11, 2022